Claims and counterclaims on Covid-19 'conspiracy'
Once more we find Karim’s presence and influence in these organisations that led our understanding of Covid-19 and the official response.
Stay updated with breaking news from Sisonke Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Once more we find Karim’s presence and influence in these organisations that led our understanding of Covid-19 and the official response.
Saimbarashe Takuva, Azwi Takalani, and colleagues investigate the frequency and incidence of adverse events reported after receipt of a single dose of the Ad26.COV2.S COVID-19 vaccine among health care workers in South Africa.
The Sisonke study team is launching the Sherpa Study that will assess the Moderna booster in protecting against COVID-19 infections and severe COVID-19 disease among healthcare workers.
A new study shows that people who receive a second dose of the Johnson & Johnson Covid-19 vaccine are less likely to end up in hospital for the disease.
A new study shows that people who receive a second dose of the Johnson & Johnson (J&J) Covid-19 vaccine are less likely to end up in hospital for the disease. The study, published in the New England Journal of Medicine by the Sisonke Study team, is one of the first real-world studies on vaccine effectiveness against the Omicron variant of the virus that causes Covid-19.